ARCHIVES

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

This article is from The Cancer Letter archive.

Vol. 31 No. 18 | May 6, 2005

Download PDF Visit The Full Archive

Related Articles

NSABP Operations Office Moves Across Town To Allegheny

December 13, 1996

McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.

June 2, 2000

In Brief: Dickersin Named To NCAB; Gallo To Retire; FASEB Suggests 10% Increase For NIH

January 20, 1995

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

Funding Opportunities: RFAs For Mouse Models Consortium, Urology Research Centers

August 7, 1998

Review Of Cancer, AIDS Drugs Starts At Jan. Meeting

December 2, 1988